3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Rectal Neoplasms
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Leukemia
5
Colonic Neoplasms
5
Multiple Myeloma
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Immunoblastic Lymphadenopathy
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Sezary Syndrome
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Esophageal Neoplasms
3
Congenital Abnormalities
3
Interventions
Gemcitabine
19
Cisplatin
11
Capecitabine
9
Oxaliplatin
7
Fluorouracil
5
pembrolizumab
4
Leucovorin
4
Sorafenib
3
Magnetic Resonance Spectroscopy
3
Erlotinib Hydrochloride
3
trifluridine tipiracil drug combination
2
regorafenib
2
cobimetinib
2
atezolizumab
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Platinum
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Lapatinib
2
Biopsy
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
varlilumab
1
vandetanib
1
tucatinib
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gallbladder Neoplasms
×
Gene Expression Profiling
×
Clear all
No trials found.